Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Bulgaria Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20071
20081
20091
20101
20111
20131
20141
20191
20201
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca2
Boehringer Ingelheim1
Centocor, Inc.1
Cogentus Pharmaceuticals1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sanofi1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction14
Stroke7
Acute Coronary Syndrome6
Cardiovascular Diseases5
Coronary Artery Disease4
Angina, Unstable2
Myocardial Ischemia2
Non-ST Elevated Myocardial Infarction2
ST Elevation Myocardial Infarction2
Atherosclerosis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.